Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Albuminuria in RA: No Cardiometabolic Risk Link

Arthritis Care Res; ePub 2017 Mar 3; Sammut, et al

There was no link in the rheumatoid arthritis (RA) group of elevated urine albumin:creatinine (uACR) with measures of atherosclerosis, nor with several key cardiometabolic risk factors, suggesting a lower utility for elevated uACR as an indicator of subclinical cardiovascular disease (CVD) in RA, according to a recent study. Urine albumin from a spot morning collection was measured and the ratio of uACR calculated for RA and a population-based sample of demographically matched non-RA controls. 196 RA patients were compared with 271 non-RA controls. Researchers found:

  • Elevated uACR was found in 18% of the RA patients vs 17% of the controls.
  • After adjustment, RA was associated with 67% lower odds of elevated uACR.
  • Higher serum creatinine levels and hypertension were both strongly and significantly associated with elevated uACR in the control group, but not in the RA group.

Citation:

Sammut A, Shea S, Blumenthal RS, et al. Albuminuria in rheumatoid arthritis: Associations with RA characteristics and subclinical atherosclerosis. [Published online ahead of print March 3, 2017]. Arthritis Care Res. doi:10.1002/acr.23234.